Analysis of the Risk of Upper Gastrointestinal Symptoms with Dipeptidyl Peptidase-4 Inhibitors Using the Adverse Event Spontaneous Reporting Database and the Receipt Database

○Ayana Funabashi

[29P-am434] Analysis of the Risk of Upper Gastrointestinal Symptoms with Dipeptidyl Peptidase-4 Inhibitors Using the Adverse Event Spontaneous Reporting Database and the Receipt Database

○Ayana Funabashi^1,2, Hitoshi Ito³, Mamoru Maeda³, Yoshitaka Hasegawa³, Ryota Tsukioka³, Mitsuko Onda² (1. AIN PHARMACIEZ INC., 2. OMPU., 3. AIN HOLDINGS INC.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[29P-am] Social Pharmacy

[29P-am434] Analysis of the Risk of Upper Gastrointestinal Symptoms with Dipeptidyl Peptidase-4 Inhibitors Using the Adverse Event Spontaneous Reporting Database and the Receipt Database

Password